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2 	
Abstract  30	
 31	
STAT3 is an oncogenic transcription factor exerting its functions both as a canonical transcriptional 32	
activator and as a non-canonical regulator of energy metabolism and mitochondrial functions. 33	
While both activities are required for cell transformation downstream of different oncogenic 34	
stimuli, they rely on different post-translational activating events, namely phosphorylation on either 35	
Y705 (nuclear activities) or S727 (mitochondrial functions). Here, we report the discovery of the 36	
unexpected STAT3 localization to the Endoplasmic Reticulum (ER), from where it modulates ER-37	
mitochondria Ca2+ release by interacting with the Ca2+ channel IP3R3 and facilitating its 38	
degradation. The release of Ca2+ is of paramount importance for life/death cell decisions, as 39	
excessive Ca2+ causes mitochondrial Ca2+ overload, the opening of the mitochondrial permeability 40	
transition pore and the initiation of the intrinsic apoptotic program. Indeed, STAT3 silencing 41	
enhances ER Ca2+ release and sensitivity to apoptosis following oxidative stress in STAT3-42	
dependent mammary tumor cells, correlating with increased IP3R3 levels. Accordingly, basal-like 43	
mammary tumors, which frequently display constitutively active STAT3, show an inverse 44	
correlation between IP3R3 and STAT3 protein levels. These results suggest that STAT3-mediated 45	
IP3R3 down-regulation in the ER crucially contributes to its anti-apoptotic functions via 46	
modulation of Ca2+ fluxes.	  47	
3 	
Introduction 48	
Signal Transducer and Activator of Transcription 3 (STAT3) is a pleiotropic transcription 49	
factor mediating the signaling of cytokines, growth factors and oncogenes1. It becomes 50	
transcriptionally activated via phosphorylation on its Y705 residue, which allows productive 51	
dimerization, concentration into the nucleus and DNA binding. STAT3 is able to activate a wide 52	
variety of target genes, modulating many cellular functions at both the physiological and 53	
pathological level. In particular, STAT3 is considered an oncogene in virtue of the observation that 54	
its constitutive activation is detected in many tumors of both solid and liquid origin, which often 55	
become addicted to its activity for growth and survival1, 2. This is corroborated by the detection of 56	
somatic activating mutations associated to cell transformation in inflammatory hepatocellular 57	
adenomas3 and in hematological neoplasms4. Accordingly, STAT3 nuclear activity was shown to be 58	
required for cellular transformation downstream of several oncogenes that trigger its 59	
phosphorylation on Y705 (Y-P), the prototype being vSrc5. In tumors, STAT3 activity can drive 60	
survival, resistance to apoptosis and to chemotherapy, migration and invasion, epithelial to 61	
mesenchymal transition, immune evasion and stemness6. Additionally, STAT3 can regulate energy 62	
metabolism, and its constitutive activation triggers a metabolic switch towards aerobic glycolysis, 63	
contributing to cell transformation and tumor cells survival7, 8. STAT3 can also be phosphorylated 64	
on S727 (S-P) downstream of both classical STAT3-activating pathways and of RAS proteins9, 10, 11. 65	
S-P is thought to mediate STAT3 non-canonical functions via localization to mitochondria10, 12. 66	
Mitochondrial STAT3 is required to maintain the activity of the Electron Transfer Complexes 67	
(ETC) under stress conditions or oncogenic transformation mediated by RAS oncogenes, while at 68	
the same time increasing aerobic glycolysis and decreasing ROS production, possibly by 69	
associating to Complex I and by favoring the formation of respiratory super-complexes10, 12, 13. 70	
Additionally, mitochondrial STAT3 participates in calcium (Ca2+) homeostasis by enhancing the 71	
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uptake of Ca2+ by mitochondria and its release into the cytosol during IL-6-mediated T cell 72	
activation13. 73	
Ca2+ homeostasis plays a major role in regulating cellular energetics and life/death 74	
decisions14, and the endoplasmic reticulum (ER) is the major intracellular Ca2+ storage 75	
compartment. Ca2+ release occurring at the apposition of ER and mitochondrial membranes, known 76	
as the Mitochondrial Associated Membranes (MAMs)15, controls the entry of Ca2+ in the 77	
mitochondrial matrix16. The main effectors of the ER Ca2+ release pathway are the inositol 1,4,5-78	
triphosphate receptors (IP3R), ligand-gated channels activated by the second messenger IP3, which 79	
is generated in response to many different extracellular signals17.	While controlled Ca2+ release 80	
leads to the activation of mitochondria oxidative phosphorylation (OXPHOS) activity and ATP 81	
production, continuous or excessive release of Ca2+ leads to mitochondrial Ca2+ overload, the 82	
opening of the mitochondrial permeability transition pore and the initiation of the intrinsic apoptotic 83	
program18, 19. Thus, regulation of the abundance and activity of the IP3Rs, and in particular of 84	
IP3R3, which is the main isoform expressed in most cultured cell lines20 and is known to be 85	
preferentially involved in transmitting apoptotic Ca2+ signals to mitochondria21, plays a crucial role 86	
in determining the sensitivity of cells to apoptotic stimuli, in particular those acting via ER Ca2+ 87	
release such as, for example, H2O2 and menadione22. Accordingly, several oncogenes and 88	
oncosuppressors, such as for example AKT, PTEN and PML, have been shown to regulate IP3R3 89	
activity and abundance, thus modulating sensitivity to apoptosis22, 23, 24, 25. 90	
Here, we report the discovery that constitutively active STAT3 can regulate Ca2+ fluxes by 91	
localizing to the ER and MAMs and interacting with IP3R3, facilitating its degradation and 92	
enhancing cellular resistance to apoptotic stimuli. This appears to be a relevant mechanism in 93	
cancer, since STAT3 and IP3R3 levels are inversely correlated in basal-like mammary tumors, 94	
which often rely on constitutively active STAT3. 95	
  96	
5 	
Results 97	
STAT3 activity affects ER Ca2+ transfer and apoptotic responses. We have previously reported 98	
that constitutively active STAT3 causes a metabolic switch towards glycolysis, coupled to HIF-99	
independent decreased mitochondrial activation as measured by mitochondrial Ca2+ uptake upon 100	
ATP stimulation7. Consistent with these findings, STAT3C MEF cells, which express a 101	
constitutively active STAT3 allele, displayed a statistically significant decrease in ER Ca2+ release 102	
when the cells were stimulated with ATP, an agonist that evokes a rapid discharge from inositol 103	
1,4,5- phosphate receptors (IP3Rs) through interaction with G protein coupled receptors, reflecting 104	
a slower flow of Ca2+ through the IP3R, as monitored by means of an ER-targeted Ca2+-sensitive 105	
aequorin probe (Supplementary Fig. S1A, B). We thus decided to assess the role of STAT3 in 106	
regulating ER Ca2+ fluxes in human breast cancer cell lines, either displaying or not constitutive 107	
STAT3 activity (Supplementary Fig. S2). Strikingly, ER Ca2+ release was significantly increased 108	
upon inducible STAT3 silencing in MDA-MB-468 and MDA-MB-231 cells (Fig. 1A, B  and 109	
Supplementary Fig. S1C, D), which display constitutive STAT3 phosphorylation on both Y705 and 110	
S727 (Supplementary Fig. S2) and are addicted to STAT3 activity. In contrast, STAT3 silencing did 111	
not affect ER Ca2+ release and content in the STAT3-independent MDA-MB-453 (Fig. 1C, D) and 112	
T47D (Supplementary Fig. S1F) cell lines, where STAT3 is not activated (Supplementary Fig. S2). 113	
Thus, similar to the STAT3C MEFs, constitutive STAT3 activity controls Ca2+ homeostasis at the 114	
ER compartment in STAT3-dependent breast cancer cells. 115	
Oxidative stress can cause apoptosis by eliciting excessive Ca2+ release from the ER, which 116	
in turn triggers excessive Ca2+ intake into the mitochondria and the activation of the intrinsic 117	
apoptotic program16. In order to assess whether the alteration in ER Ca2+ release observed in the 118	
STAT3-dependent tumor cells upon STAT3 silencing correlates with altered apoptotic responses, 119	
we measured apoptosis in MDA-MB-468 cells, silenced or not for STAT3. Cells were treated with 120	
H2O2 or menadione, two oxidizing agents known to induce ER Ca2+ release and calcium-mediated 121	
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cell death22, and apoptosis was measured by means of Annexin V analysis (Fig. 1E). Interestingly, 122	
STAT3 silencing enhanced cell death in response to both H2O2 and menadione but not to the 123	
genotoxic compound etoposide, whose mechanism of induced cell death is independent of Ca2+ 22. 124	
Analogous results were obtained with MDA-MB-231 cells (Supplementary Fig. S1E). Accordingly, 125	
cytosolic Ca2+ concentration was significantly increased by treatment of STAT3-silenced MDA-126	
MB-468 cells with H2O2 and menadione, but not etoposide (Fig. 1F-H). Consistently, neither 127	
apoptosis nor cytosolic Ca2+ were affected by STAT3 silencing in MDA-MB-453 or T47D cells 128	
(Fig. 1 I-N and Supplementary Fig. S1 G, H). Taken together, these results suggest that 129	
constitutively active STAT3 can reduce ER Ca2+ release upon oxidative stresses, thus inhibiting the 130	
apoptotic response. 131	
 132	
STAT3 localizes to the ER and MAM compartments, where it interacts with IP3R3. Since 133	
STAT3 was shown to localize to several cellular compartments including the mitochondrion26, we 134	
assessed its subcellular localization in MDA-MB-468 cells. Strikingly, we observed that both the 135	
ER and the MAMs, the highly specialized ER compartment mediating communication with the 136	
mitochondrion, contained abundant STAT3, phosphorylated on both Y and S (Fig. 2A). A similar 137	
localization was also observed in primary MEFs and in the liver (Supplementary Fig. S3A, B). 138	
STAT3 was less abundant in the ER and MAMs of MDA-MB-453 and T47D breast tumor cells, 139	
where very little, if any, Y- or S-phosphorylated STAT3 was detected  (Supplementary Fig. S3C, 140	
D). Thus, STAT3 may be responsible of regulating Ca2+ fluxes in response to apoptotic stimuli from 141	
within the ER and MAM compartments. In search for a possible mechanism, we assessed potential 142	
STAT3 interactions with known regulators of ER Ca2+ release, including the calcium channel 143	
IP3R3. Intriguingly, we observed a clear interaction of STAT3 with IP3R3, as evidenced by co-144	
immunoprecipitation with anti-STAT3 antibodies (Fig. 2B). Of note, STAT3:IP3R3 interaction was 145	
detected not only in whole cell extracts, but also in purified ER and MAM fractions of MDA-MB-146	
7 	
468 cells, supporting the idea that the observed modulation of Ca2+ release is operated by ER- and 147	
MAM-localized STAT3. STAT3 and IP3R3 co-immunoprecipitated also from extracts of MDA-148	
MB-453 cells (Supplementary Fig. S3E), despite their failure to display enhanced Ca2+ release or 149	
apoptosis upon STAT3 silencing. Thus, the mere interaction between STAT3 and IP3R3 is not 150	
sufficient to elicit a phenotype, strongly suggesting the involvement of differential phosphorylation 151	
instead. Importantly, the interaction was also detected using anti-IP3R3 antibodies in both cell types 152	
(Supplementary Fig. S3F).  153	
Despite being an ER transmembrane protein, most of IP3R3 faces the cytosolic side, where it has 154	
been shown to interact with several proteins such as, for example, AKT, PML and PTEN22, 23. In 155	
agreement with the idea that STAT3 may also interact with IP3R3 on the cytosolic side, both IP3R3 156	
and STAT3 were eliminated from the ER fraction of MDA-MB-468 cells upon Proteinase K 157	
digestion, while the internal ER protein PDI was retained (Fig. 2C). As determined by co-IP 158	
experiments, both STAT3 coiled-coiled and DNA binding domains are involved in the interaction 159	
with IP3R3 (Supplementary Fig. S4A). Conversely, the N terminal domain of IP3R3, and more 160	
precisely the region between the residues 602 and 800, is engaged in the interaction with STAT3 161	
(Supplementary Fig. S4B) 162	
 163	
STAT3 S727 is involved in regulating Ca2+ release and apoptosis. 164	
In order to assess the role of STAT3 phosphorylation on either Y705 or S727 in regulating ER Ca2+ 165	
release and apoptosis, we reconstituted STAT3 null MEFs with FLAG-tagged STAT3, either wild 166	
type or mutated in the Y705 or the S727 residues (YF, SA). SA-mutated STAT3 is still detected in 167	
the ER and MAM fractions, albeit at a considerably reduced level as compared to the WT or YF 168	
forms, particularly in the MAMs (Fig. 3A). Likewise, all three STAT3 forms still co-169	
immunoprecipitate with IP3R3 (Fig. 3B). These data suggest that phosphorylation on the Y or S 170	
residues is not absolutely required for either the ER/MAM localization or the interaction with 171	
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IP3R3. Next, we investigated ER Ca2+ homeostasis. Interestingly, while MEFs expressing either the 172	
WT or the YF forms released comparable amounts of Ca2+ upon ATP stimulation, cells 173	
reconstituted with the SA form displayed significantly increased Ca2+ release, suggesting that 174	
phosphorylation on Serine 727 is involved in STAT3-mediated regulation of Ca2+ fluxes (Fig. 3C, 175	
D). This idea is confirmed by the observation that, compared with WT- or YF-reconstituted cells, 176	
MEFs reconstituted with SA STAT3 displayed significantly enhanced apoptotic responses to H2O2 177	
and menadione, but not to etoposide (Fig. 3E), similar to what observed in the MDA-MB-468 cells 178	
silenced for STAT3. Accordingly, SA-reconstituted MEFs displayed extremely higher levels of 179	
cytosolic calcium upon H2O2 treatment, as compared with the WT or YF cells (Fig. 3F), in 180	
agreement with a central role of S-P STAT3 in regulating ER Ca2+ release and apoptosis. 181	
 182	
STAT3 activity regulates IP3R3 protein levels. 183	
Our data suggest that STAT3, by interacting with IP3R3, may regulate its ability to release Ca2+ in 184	
response to either ATP,  H2O2 or menadione. IP3R3 is known to be regulated at least partly via 185	
ubiquitination and proteasome degradation25. Interestingly, when analyzing the protein data 186	
available from CPTAC, the TCGA Cancer Proteome Study of Breast Tissue27,	 we detected a 187	
negative correlation between STAT3 and IP3R3 protein levels (Fig. 4A,B). This was statistically 188	
significant within the basal-like breast cancer subtype, where STAT3 is often constitutively 189	
activated (Fig. 4B). In line with this observation, STAT3 silencing in the MDA-MB-468, but not in 190	
the MDA-MB-453, cells resulted in significant up-regulation of IP3R3 protein levels (Fig. 4 C,D), 191	
suggesting that indeed constitutively active STAT3 can control IP3R3 activity by downregulating 192	
its levels. We have recently reported that IP3R3 levels are significantly down-regulated upon serum 193	
starvation and re-feeding25. We thus wondered whether STAT3 activity might facilitate this 194	
degradation. Indeed, serum starvation/re-feeding resulted in significant down-regulation of IP3R3 195	
protein levels in MDA-MB-468 cells, strikingly correlating with a significant increase in the levels 196	
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of serine-phosphorylated STAT3 (Fig. 4E and Supplementary Fig. S5C). This was dependent on 197	
proteasome activity and completely abolished by STAT3 silencing (Supplementary Fig. S5A and 198	
Fig. 4E). Of note, IP3R3 mRNA was not affected (Supplementary Fig. S5B). Intriguingly, 199	
expression of the STAT3-SA mutant in the silenced MDA-MB-468 cells failed to rescue IP3R3 200	
degradation (Fig. 4E and Supplementary Fig. S5D). Taken together, these data suggest a link 201	
between S727 phosphorylation and the down-regulation of IP3R3 levels, in keeping with the results 202	
obtained in MEFs. Further suggesting that IP3R3 degradation requires STAT3 activity, no changes 203	
in IP3R3 expression were detected in MDA-MB-453 cells upon either STAT3 silencing or serum 204	
starvation and refeeding, while the same cells overexpressing STAT3 underwent both STAT3 205	
Serine phosphorylation and IP3R3 degradation (Fig. 4F and Supplementary Fig. S5C,E). Of note, 206	
silencing of IP3R3 in MDA-MB-468 cells can recapitulate the effects of STAT3 activation on Ca2+ 207	
homeostasis (Supplementary Fig. S5 F,G), further supporting our conclusions. 208	
 209	
Discussion 210	
The regulation of calcium fluxes between the ER and mitochondria is crucial for the physiological 211	
and pathological regulation of energy metabolism and to inform cell decisions between energy 212	
production, and life, or apoptotic death. It is thus not surprising that the players involved in this 213	
equilibrium act as central signaling platforms for the activity of growth factors, oncogenes and 214	
oncosuppressors at the ER-mitochondria interface16, 28. For example the activity of IP3R3 is 215	
regulated by a growing list of proteins that, mostly at MAMs, cooperate to modulate the activation 216	
of downstream pathways. Among them we would mention AKT, which destabilizes IP3R3 thus 217	
decreasing Ca2+ release and apoptosis, the stabilizing oncosuppressor PML22, the antiapoptotic Bcl-218	
2 that inhibits Ca2+ transfer from ER to mitochondria by targeting IP3 receptors29, and the 219	
chaperone Sig1R mainly involved in cell survival30. Noteworthy, recent findings highlighted the 220	
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ability of the PTEN and BAP1 oncosuppressors to stabilize IP3R323, 24, 25. Accordingly, a wealth of 221	
data suggest a key role for this isoform in Ca2+ signaling and cell death 31, 32, 33, 34. 222	
STAT3 is a well recognized oncogene with potent anti-apoptotic functions, which have been linked 223	
both to its canonical nuclear activities, such as the direct regulation of anti-apoptotic genes 224	
transcription, and to its non-canonical functions exerted via localization to mitochondria, where it 225	
interacts with ETC components enhancing their activity while reducing ROS production, mediating 226	
RAS oncogenes-induced cell transformation10, 12, 35. Importantly, these non-canonical functions 227	
require STAT3 phosphorylation on S727 rather than on Y705. We have previously reported that 228	
constitutively active STAT3 enhances aerobic glycolysis, decreasing at the same time 229	
mitochondrial Ca2+ uptake, membrane polarization and OXPHOS activity, correlating with 230	
protection from apoptosis7. The mechanisms dictating these mitochondrial phenotypes are however 231	
still unclear. Here we report that constitutively active STAT3 can reduce ER Ca2+ release. This 232	
correlates with resistance to apoptotic stimuli such as H2O2 and menadione, known to trigger Ca2+-233	
mediated cell death, but not to a Ca2+-independent genotoxic stress such as etoposide22. Indeed, the 234	
STAT3-dependent MDA-MB-468 and MDA-MB-231 mammary tumor cells, which display 235	
constitutively active STAT3, become sensitive to Ca2+-mediated cell death upon STAT3 silencing, 236	
while STAT3-independent MDA-MB-453 or T47D cells are not affected by the absence of STAT3. 237	
The observation that the enhanced sensitivity of MDA-MB-468 cells to apoptosis correlates with 238	
increased cytosolic Ca2+ in response to H2O2 and menadione in MDA-MB-468, but not in MDA-239	
MB-453 cells, corroborates the idea that constitutively active STAT3 protects cells from specific 240	
apoptotic stimuli via the regulation of Ca2+ transfer from the ER. The further observation that 241	
STAT3, both phosphorylated on Y705 and on S727, localizes abundantly to the ER and the MAMs, 242	
where it interacts with IP3R3, provides a mechanistic explanation for this novel non-canonical 243	
activity of STAT3. In keeping with the previous knowledge about degradation-mediated IP3R3 244	
regulation16, 24, 25, we found that STAT3 silencing increases IP3R3 levels and inhibits its 245	
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degradation upon serum starvation and refeeding in STAT3-dependent cells. These data suggest 246	
that constitutively active STAT3 can promote IP3R3 degradation, thus reducing Ca2+ exit from the 247	
ER and apoptosis. It should be noted that some reports challenge the view of IP3R3 and Ca2+ fluxes 248	
to the mitochondria as part of the apoptotic machinery. For example, an increased expression of 249	
IP3R3 was noted in tumors36, 37, where an efficient ER-mitochondrial Ca2+ transfer was proposed to 250	
ensure the activity of Ca2+-dependent enzymes sustaining DNA synthesis and proliferation. 251	
Likewise, although reduced mitochondrial Ca2+ uptake was shown to allow cells to escape from 252	
apoptosis, Ca2+ fluxes towards mitochondria through the mitochondrial calcium uniporter appear to 253	
improve tumor growth and cell migration38, 39. Thus, like most metabolic parameters, also the role 254	
of Ca2+ signaling is likely continuously reshaped during the cell transformation route and under 255	
different conditions. Interestingly, phosphorylation on either Y705 or S727 is not strictly required 256	
for ER STAT3 localization, or for its interaction with IP3R3. However, our experiments with MEF 257	
cells reconstituted with tyrosine- or serine-mutated STAT3 clearly indicate that S727, but not Y705, 258	
is required for STAT3-mediated regulation of both ER Ca2+ fluxes and apoptosis. The additional 259	
observation that a STAT3 mutated on Serine 727 fails to rescue the ability of STAT3-silenced 260	
MDA-MB-468 cells to undergo IP3R3 degradation upon serum starvation and refeeding further 261	
supports the idea that SP-STAT3 regulates Ca2+ fluxes via controlling IP3R3 degradation. It can be 262	
speculated that serine phosphorylation, not required for STAT3-IP3R3 interaction, might be crucial 263	
for STAT3-mediated IP3R3 destabilization by either affecting its structure or recruiting some 264	
crucial component of the degradation complex. An alternative explanation is provided by the 265	
observation that the proportion of total STAT3 localizing to the ER is much lower not only in MEF 266	
cells reconstituted with the SA STAT3 mutant as compared to those expressing either the WT or the 267	
YF mutant form, but also in the STAT3-independent MDA-MB-453 and T47D cells with respect to 268	
the STAT3-dependent MDA-MB-468 cells. This suggests the possibility that STAT3 269	
phosphorylation on S727 facilitates STAT3 ER localization and function, which might become 270	
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uninfluential below a certain threshold. Supporting the relevance of our findings is the observation 271	
that the levels of the two proteins are inversely correlated in basal-like breast cancer, where STAT3 272	
constitutive activation plays a prominent role40. 273	
In the recent years, the pro-oncogenic role of S-P STAT3 has been demonstrated in many 274	
experimental systems, mostly linked to its functions in the mitochondrion26. However, the 275	
observation of very low molar ratios between mitochondrial STAT3 and ETC components has 276	
questioned the interpretation of a direct role of mitochondrial STAT3 in regulating ETC activities41. 277	
Besides the consideration that STAT3 abundance and role in the mitochondria is probably subjected 278	
to cell type and context variations, our data suggest now an additional non-canonical, pro-oncogenic 279	
and anti-apoptotic role exerted by constitutively phosphorylated STAT3 via its S727 residue. 280	
 281	
Materials and Methods 282	
Cell lines, transfections and animals 283	
The breast cancer cell lines MDA-MB-468, MDA-MB-453, MDA-MB-231 and T47D were 284	
obtained from ATCC (Manassas VA, USA) and expanded at the Molecular Biotechnology Center 285	
(MBC). Mice were maintained in the transgenic unit of the MBC in conformity with national and 286	
international laws and policies as approved by the Faculty Ethical Committee and by the Ministery 287	
of Health. Livers were collected from 8-weeks old mice. Immortalized STAT3-null MEF cells were 288	
obtained as previously described42. Cell lines were grown in Dulbecco's modified Eagle medium 289	
(DMEM) with GLUTAMAX (Gibco-BRL, Carlsbad CA, USA), supplemented with 10% (v/v) 290	
heat-inactivated FCS, 100 U/ml penicillin and 100 µg/ml streptomycin (Gibco-BRL, Carlsbad CA, 291	
USA). HEK293 cells were transiently transfected with pCDNA3 vectors carrying truncated forms 292	
of STAT3 and IP3R3 using Lipofectamine 2000 or Lipofectamine LTX systems (Lifetechnologies, 293	
Invitrogen, Carlsbad, CA, USA), according to manufacturer's instructions. STAT3 null MEF cells 294	
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were transfected with pCEP4 vectors carrying WT or mutated (YF and SA) STAT3 forms, and 295	
stably expressing clones were selected with hygromycin. 296	
Transduction with lentiviral vectors 297	
Lentiviral viruses were packaged by transfecting 293T cells and used to infect cells for 24 hours. 298	
For conditional RNA interference, the vectors pLV-DsRed-tTR-KRAB and the pLVTH-GFP-299	
shRNA43, either empty or carrying an shSTAT3 sequence as described44, were produced. Cells were 300	
transduced at high efficiency with both lentiviral particles. Transduced cells were treated with 301	
doxycycline (1 µg/ml) for 12 hours, followed by sorting of cells doubly positive for GFP and 302	
DsRed. STAT3 silencing was induced by 72 hours doxycycline treatment (1 µg/ml). For the 303	
overexpression of STAT3, pLVX lentiviral vectors expressing either wild type or SA STAT3, 304	
retromutated to make them sh-resistant, were used. 305	
 306	
Calcium measurements. 307	
Cells were grown on glass coverslips at 50% confluence and ER Ca2+ measurements were 308	
performed as described45. Briefly, cells were infected with a lentiviral vector expressing the ER-309	
aequorin chimera (ER-GFP-AEQm-pLV) for 48 hours, then	 to reconstitute the probe with high 310	
efficiency, the luminal [Ca2+] of the ER was first reduced by incubating the cells for 45 min at 4°C 311	
in Krebs–Ringer modified buffer (KRB; 125 mM NaCl, 5 mM KCl, 1 mM Na3PO4, 1 mM 312	
MgSO4, 5.5 mM glucose, and 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 313	
[HEPES], pH 7.4, at 37°C) supplemented with 5 µM coelenterazine, the Ca2+ ionophore ionomycin, 314	
and 600 µM ethylene glycol tetraacetic acid (EGTA). After incubation, the cells were extensively 315	
washed with KRB supplemented with 2% bovine serum albumin and 2 mM EGTA before the 316	
luminescence measurement was initiated. Aequorin signals were measured in KRB supplemented 317	
with either 1 mM CaCl2 or 100 µM EGTA, using a purpose-built luminometer (see 46 for complete 318	
details). The cytosolic Ca2+ response was evaluated essentially as described47, making use of the 319	
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fluorescent Ca2+ indicator Fura-2 AM (Life technologies, Invitrogen). Briefly, cells were loaded 320	
with Fura-2 AM for 15 min, placed in an open Leyden chamber on a 37°C thermostat controlled 321	
stage and treated with 1 mM H2O2. Fluorescence data at 340/380 nm were collected and expressed 322	
as calcium concentration (nM). 323	
Detection of cell death 324	
Cells were treated O/N with 1mM H2O2, 15 µM Menadione or 150 M Etoposide (Sigma Aldrich, 325	
St. Louis MO, USA), followed by staining with Annexin-V and Propidium Iodide according to 326	
manufacturer's protocol. Apoptosis was determined on a FACS Calibur cytometer (Beckton, 327	
Dickinson and Company, Franklin Lakes NJ, USA). 328	
Antibodies, Western blotting and Co-immunoprecipitations 329	
Protein extracts were prepared with lysis buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.4, 0.1% NP-330	
40, 0.002 M EDTA, 5% glycerol) supplemented with 1 mM PMSF and proteases/phosphatases 331	
inhibitors, fractionated on SDS-PAGE (4-12% precast gel, Lifetechnologies, Carlsbad CA, USA) 332	
and transferred to a polyvinylidene difluoride membrane (Millipore, Billerica MA, USA). Blots 333	
were probed using the following antibodies: mouse anti-IP3R-3 (cat. 610313, BD-Pharmingen, San 334	
Diego CA, USA), rabbit anti-STAT3 (clone K15, cat. sc-483), rabbit anti-HA (cat. sc-805, Santa 335	
Cruz Biotechnologies, Dallas, Texas, USA), rabbit anti-PY (cat. 9131) and anti-PS STAT3 (cat. 336	
9134), mouse anti-H3 (cat. 3638), rabbit anti-myc tag (cat. 2278, Cell Signaling, Danvers MA, 337	
USA), mouse anti-PDI (cat. ab2792) and rabbit anti-VDAC1 (cat. ab15895, Abcam, Cambridge, 338	
UK), rabbit anti-SIGMAR1 (cat. HPA018002), mouse anti-alphatubulin (cat. T5168), rabbit anti-339	
FLAG (cat. F7425) and mouse anti-vinculin (cat. SAB4200080, Sigma Aldrich, St. Louis MO, 340	
USA). Isotype matched, horseradish peroxidase conjugated secondary antibodies were used 341	
followed by detection by chemiluminescence (Sigma Aldrich, St. Louis MO, USA). 342	
For co-immunoprecipitation experiments, freshly prepared pre-cleared lysates were incubated O/N 343	
at 4°C with goat anti-IP3R3 (cat. sc-7277, Santa Cruz Biotechnologies, Dallas, Texas, USA) or 344	
15 	
rabbit anti-STAT3 (cat. 10253-2-AP, Proteintech, Rosemont IL, USA) antibodies. Protein G or A 345	
beads, respectively (Ge Healthcare Bio-Science, Uppsala, Sweden), were added and rocked 2 hours 346	
at 4°C. Immunoprecipitations with anti-FLAG and anti-HA were performed by using ANTI-FLAG 347	
M2 Affinity Gel (cat. A2220) and Mouse Monoclonal Anti-HA-Agarose antibody (cat. A2095, 348	
Sigma Aldrich, St. Louis MO, USA) for 3 hours at 4°C. Immunoprecipitated proteins were boiled 349	
in 1x Laemmli buffer for 10 minutes prior to loading on SDS page. 350	
Subcellular fractionations 351	
Cells were fractionated as previously described48.	 Briefly, cells were harvested, washed in 352	
phosphate-buffered saline medium, resuspended in homogenization buffer and gently disrupted by 353	
dounce homogenisation. The homogenate was then submitted to different super- and ultra-354	
centrifugation steps to obtain the indicated fractions. 355	
Proteinase K digestion 356	
The ER fraction was incubated with 50 µg/ml or 250 µg/ml of proteinase K for 30 minutes on ice, 357	
in the presence or not of 0.3% Triton-X 100. Samples were boiled in Laemmli buffer for 10 minutes 358	
prior to SDS-PAGE separation. 359	
IP3R3 degradation assay 360	
After silencing induction (see above), cells were serum-starved with 0.1% FCS in the presence of 361	
doxycyclin for 72 hours, followed by FCS re-feeding in the presence of 100 M ATP (Sigma 362	
Aldrich, St. Louis MO, USA). Samples were lysed and submitted to SDS-PAGE separation. For 363	
proteasome inhibition, two hours before refeeding cells were treated with 40 µM MG132 (dissolved 364	
in dimethyl sulfoxide, DMSO), or with DMSO alone. IP3R3 levels were then detected by Western 365	
blot as described above. 366	
RNA isolation and Real Time PCR 367	
Total RNA was extracted using Trizol reagent (Lifetechnologies, Invitrogen, Carlsbad CA, USA) 368	
and used for cDNA synthesis with High Capacity Retrotranscription kit (Lifetechnologies, Applied 369	
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Biosystems, Waltham MA, USA). qRT-PCR reactions were performed using the Universal Probe 370	
Library system (Roche Italia, Monza, Italy). The 18S rRNA pre-developed TaqMan assay 371	
(Lifetech, Applied Biosystems, Waltham MA, USA) was used as an internal control.  Primer 372	
sequences were as follows: hIP3R3 L, 5’-tcgtgaagtatggcagtgtga-3’, hIP3R3 R, 5’-373	
gaagccgcttgttcactgtc-3’; probe: 17. 374	
Statistical analysis 375	
Unpaired t test was used to calculate a P value for two groups. P values on a response affected by 376	
two factors were calculated with one-way or two-way ANOVA. P values are indicated as follows: 377	
*p < 0.05, **p < 0.005,  ***p < 0.001. 378	
 379	 	  380	
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Figure legends 381	
Figure 1 Relevance of STAT3 in Ca2+ homeostasis and apoptotic response. MDA-MB-468 (A, B, 382	
E-H) or MDA-MB-453 cells (C, D, I-N), silenced or not for STAT3 (shS, shSTAT3; shC, sh 383	
control) were used as indicated. (A-D) ER Ca2+ content and release. To induce Ca2+ release from 384	
ER, the cells were challenged with ATP that evokes a rapid discharge from inositol 1,4,5-phosphate 385	
receptors (IP3Rs). (A, C) Representative traces are shown. ER calcium release (mean ± SEM) is 386	
quantified by the bars and expressed as µM/sec. (B, D) show the steady state Ca2+ content. Bars are 387	
mean± SEM of at least 8 traces from 3 independent experiments. (E, I) Apoptosis upon treatment 388	
with hydrogen peroxide (H2O2), menadione (MEN) or etoposide (ETO), measured by 389	
cytofluorimetry of Annexin V/PI+ cells in the indicated cells. Bars represent the percentage of 390	
Annexin V/PI positive cells (mean±SEM from 5 independent experiments). (F-H, L-N) 391	
Cytoplasmic Ca2+ release was measured upon the indicated treatments. Bars are mean± SEM of 12 392	
measurements from 3 independent experiments. The asterisks indicate  statistically significant 393	
differences. *, p<0,05;  **, p<0,005; ***, p<0,001. 394	
 395	
Figure 2 STAT3 localizes to the ER and MAM compartments and interacts with IP3R3. (A) Whole 396	
cell lysates from MDA-MB-468 cells were fractionated and analysed by Western blot. 397	
Representative of at least 5 independent experiments. (B) Co-immunoprecipitation of STAT3 and 398	
IP3R3. Whole cell lysates or ER and MAM fractions were subjected to immunoprecipitation with 399	
anti-STAT3 antibodies (S3) or with control IgG, and blotted with the indicated antibodies. 400	
Representative of at least 5 independent experiments. WCL, whole cell lysate; ER, endoplasmic 401	
reticulum; MAM, mitochondrial associated membranes; T, total extract. (C) Whole cell lysates 402	
from MDA-MB-468 cells were treated with the indicated amounts of Proteinase K (PK) in the 403	
presence or absence of 3% Triton X-100 (Tx), and analysed by Western blot. Representative of 5 404	
independent experiments.  405	
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 406	
Figure 3 Characterization of STAT3-null MEFs replaced with WT or mutant STAT3. (A) Whole 407	
cell lysates from STAT3 null MEF cells stably expressing wild type (WT), YF- or SA-STAT3 were 408	
fractionated and analysed by Western blot. (B) HEK293 cells overexpressing IP3R3 were 409	
transiently transfected with flagged wild type or mutant STAT3 (WT, YF, SA) or with an unrelated 410	
control (UC), and immunoprecipitated with anti-flag antibodies followed by Western blot. EV, 411	
empty vector. (C, D) ER Ca2+ release (C) and content (D) induced by treatment with ATP in MEFs 412	
expressing STAT3WT (red line), STAT3YF (black line) or STAT3SA (green line), measured as 413	
described in the legend to Figure 1. Bars are mean± SEM of 10 measurements from 3 independent 414	
experiments). (E) Apoptosis in response to hydrogen peroxide (H2O2), menadione (MEN) or 415	
etoposide (ETO), assessed in STAT3WT, SA or YF MEFs by cytofluorimetric analysis of Annexin 416	
V/PI+ cells. Mean±SEM from 5 independent experiments. NT, untreated. (F) Cytoplasmic Ca2+ 417	
release in STAT3WT, SA or YF MEF cells upon H2O2 stimulation. Bars represent the mean± SEM 418	
of 16 measurements. The asterisks indicate  statistically significant differences. **, p<0,005; ***, 419	
p<0,001. 420	
 421	
Figure 4 STAT3-mediated regulation of IP3R3 protein levels in breast primary tumors and cell 422	
lines. (A, B) STAT3:IP3R3 anti-correlation in breast cancer patients from the CPTAC, TCGA 423	
Cancer Proteome Study of Breast Tissue dataset, considering all tumor subtypes (A, Pearson 424	
coefficient = -0.18, p=0.06) or basal-like tumor samples (B, Pearson coefficient = -0.41, p= 0.04). 425	
(C, D) IP3R3 levels upon STAT3 silencing in MDA-MB-468 (C) or in MDA-MB-453 (D) cells. 426	
shS, shSTAT3; shC, sh control. Bars represent mean values ± SEM of 4 independent experiments. 427	
(E, F) IP3R3 levels upon starvation and serum restimulation (SR) in MDA-MB-468 (E) or MDA-428	
MB-453 (F) cells silenced or not for STAT3 and overexpressing STAT3 SA or WT (shS, shSTAT3; 429	
shC, sh control). The graphs on the right show the relative quantification of IP3R3 levels from at 430	
19 	
least 4 independent experiments, as mean ± SEM. P values were calculated by two-way ANOVA. 431	
E, shC vs shS, p<0,001; shC vs shS+STAT3 SA, p<0,001; shS vs shS+STAT3 SA, ns. F, shC vs 432	
shS, ns; shC vs STAT3 WT, p<0,05; shS vs STAT3 WT, p<0,01. 433	
 434	
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SUPPLEMENTARY INFORMATIONS 
 
Figure S1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Silencing and apoptosis. (A, B) ER Ca2+ release (A)  and content (B) in primary MEF cells 
of the indicated genotypes (S3WT, STAT3WT/WT, black; S3C, STAT3C/C, red). To induce 
Ca2+ release from the ER, the cells were challenged with ATP. A representative trace is 
shown. ER calcium release is quantified by the bars (mean±  SEM of 10 traces from two 
independent experiments) and expressed as µM/sec. (C-E) MDA-MB-231 cells, silenced or 
not for STAT3. ER Ca2+ release (C)  and content (D) were measured as above; bars are 
mean±  SEM of 27 traces from three independent experiments. (E) Apoptotic response in 
MDA-MB-231 cells, silenced (shS, black) or not (shC, red) for STAT3, upon treatment with 
H2O2 or etoposide (ETO). NT, untreated. Bars represent the percentage of Annexin V 
positive cells (mean±SEM from at least 3 independent experiments). The asterisks indicate 
statistically significant differences. *, p<0,05.   (F-H) T47D cells, silenced or not for 
STAT3. (F) Since T47D did not respond with Calcium release to any of the treatments 
tested, Ca2+ content was measured as Ca2+-dependent ER aequorin signals upon CaCl2 
administration. shS, shSTAT3; shC, sh control. Bars are mean±  SEM of 10 traces from two 
independent experiments. (G) Apoptotic response upon treatment with H2O2, menadione 
(MEN) or etoposide (ETO). NT, untreated. Bars represent the percentage of Annexin V/PI 
positive cells (mean±SEM from at least 5 independent experiments). (H) Cytoplasmic 
calcium release upon H2O2 stimulation in T47D cells. The bars represent mean±  SEM of at 
least 12 measurements from three independent experiments.  
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Figure S2.  
 
 
 
Relative levels of STAT3 and its phosphorylation in breast cancer cells. 
(A) STAT3 silencing. The indicated cell lines were transduced with lentiviral vectors 
expressing either control (C) or STAT3 (S) shRNAs, and silencing was assessed by 
immunoblotting. (B) MDA-MB-468 and MDA-MB-453 whole cell lysates were analysed by 
Western blot with the indicated antibodies. (C) Quantification of 4 independent Western 
blots as in B. Bars represent mean±SEM of expression/phosphorylation levels of 4 
independent experiments. The asterisks indicate statistically significant differences. *, 
p<0,05; ****, p<0,001. 
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Figure S3.  
 
 
 
STAT3 localization and interaction with IP3R3. (A-D) Western blot analysis upon cell 
fractionation of MEF cells (A), liver (B), MDA-MB-453 cells (C) and T47D cells (D). 
Representative of at least 2 independent experiments. (E) STAT3:IP3R3 co-
immunoprecipitation from whole cell lysates (WCL), ER or MAM fractions of MDA-MB-
453 cells, using anti-STAT3 antibodies. Representative of at least 2 independent 
experiments. (F) IP3R3:STAT3 co-immunoprecipitation from whole cell lysates of the 
indicated cells, using anti-IP3R3 antibodies. Representative of at least 2 independent 
experiments. 
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Figure S4.  
 
 
 
Analysis of STAT3-IP3R3 interaction. (A) Co-immunoprecipitation of flagged STAT3 
proteins with endogenous IP3R3. The map describes the STAT3-FLAG constructs used. N, 
amino-terminal; CCD, coiled coiled domain; DBD, DNA binding domain; C, carboxy-
terminal domain. HEK293 cells were transiently transfected with the indicated constructs, 
whole cell lysate was immunoprecipitated with, anti-FLAG antibodies and probed with anti-
IP3R3 or FLAG antibodies. UC, unrelated flagged control; EV, empty vector; WCL, whole 
cell lysate. (B) Co-immunoprecipitation of flagged or HA-tagged IP3R3 proteins with 
STAT3-MYC. The map describes the IP3R3 constructs used. Flagged constructs: N and N3, 
MID; HA-tagged constructs: N, N1, N2, aa 227-602. The indicated constructs were 
transiently co-transfected with full length STAT-MYC, followed by anti-FLAG (left panel) 
or anti-HA (right panel) immunoprecipitation and Western blot with the indicated 
antibodies. EV, empty vector; WCL, whole cell lysate. 
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Figure S5.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IP3R3 measurements. (A) MDA-MB-468 shCTR cells were serum starved and pre-treated 
for 2 hours with MG132 prior to serum restimulation (SR) for the indicated times, plus or 
minus MG132. Whole cell lysates were analysed by Western blot. Representative of four 
independent experiments. (B) IP3R3 RNA levels as measured by Taqman RT-PCR in MDA-
MB-468 cells silenced (shS) or not (shC) for STAT3 upon starvation and serum refeeding 
(SR). Bars are mean  ±  SEM from 3 independent experiments. (C) MDA-MB-453 and MDA-
MB-468 cells were starved for 72 hours prior to serum restimulation (SR) for the indicated 
times. Whole cell lysates were analysed by Western blot. Representative of two independent 
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experiments. (D) MDA-MB-468 cells carrying the Doxycyclin-inducible shRNA against 
STAT3 were transduced with a lentiviral vector carrying an shRNA-resistant form of 
flagged SA STAT3, whose expression is shown by Western blot, plus or minus Doxycyclin 
treatment. (E) MDA-MB-453 cells stably overexpressing flagged WT STAT3 as analyzed 
by Western blot. (F-G) MDA-MB-468 cells, silenced (shIP3R3) or not (shSCR) for IP3R3. 
(F) Western blot. (G) Cytoplasmic Ca2+ release measured upon H2O2 treatment.  Bars are 
mean±  SEM of 12 measurements from 3 independent experiments.  
 
 
 
